"results suggested that down-regulation of SPOP promoted osteosarcoma (OS) cells migratory and invasive ability via modulating the "PI3K/Akt/NF-kappaB" signaling pathway; thus SPOP could be a promising drug target for the treatment of OS invasion"xsd:string